- Home
- GTLB vs SVA Comparison
GTLB vs SVA Comparison
Compare GTLB & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLB
- SVA
- Stock Information
- Founded
- GTLB 2011
- SVA N/A
- Country
- GTLB United States
- SVA
- Employees
- GTLB N/A
- SVA 3261
- Industry
- GTLB EDP Services
- SVA
- Sector
- GTLB Technology
- SVA
- Exchange
- GTLB Nasdaq
- SVA NYSE
- Market Cap
- GTLB 8.3B
- SVA N/A
- IPO Year
- GTLB 2021
- SVA N/A
- Fundamental
- Price
- GTLB $55.43
- SVA $6.47
- Analyst Decision
- GTLB Strong Buy
- SVA
- Analyst Count
- GTLB 27
- SVA 0
- Target Price
- GTLB $65.59
- SVA N/A
- AVG Volume (30 Days)
- GTLB 1.3M
- SVA N/A
- Earning Date
- GTLB 12-02-2024
- SVA N/A
- Dividend Yield
- GTLB N/A
- SVA N/A
- EPS Growth
- GTLB N/A
- SVA N/A
- EPS
- GTLB N/A
- SVA N/A
- Revenue
- GTLB $665,218,000.00
- SVA N/A
- Revenue This Year
- GTLB $30.87
- SVA N/A
- Revenue Next Year
- GTLB $24.25
- SVA N/A
- P/E Ratio
- GTLB N/A
- SVA N/A
- Revenue Growth
- GTLB 32.42
- SVA N/A
- 52 Week Low
- GTLB $40.19
- SVA N/A
- 52 Week High
- GTLB $78.53
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- GTLB 62.49
- SVA N/A
- Support Level
- GTLB $53.50
- SVA N/A
- Resistance Level
- GTLB $55.55
- SVA N/A
- Average True Range (ATR)
- GTLB 1.63
- SVA 0.00
- MACD
- GTLB 0.30
- SVA 0.00
- Stochastic Oscillator
- GTLB 73.64
- SVA 0.00
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.